The iconic rise of copyright’s flagship product presented a massive chance for shareholders , but its period has expired , creating a intricate landscape. Alternative versions have flooded the space , eroding revenues and putting a strain on profit margins . While leading healthcare companies continue a foothold in this area, the potential remain